Navigation Links
BGI Tech and BAB jointly develop transgenic mice platform for biomedical research
Date:8/7/2012

August 7, 2012, Shenzhen, China BGI Tech Solutions Co., LTD, also referred to as "BGI Tech" and BGI Ark Biotechnology Co., LTD. (BAB), a biotechnology company dedicated to large scale production of transgenic and cloned animals, today announced that they have jointly developed an advanced transgenic mice platform for boosting human diseases and medical research, with the advantages of improved efficiency, high positive rate, available sex determination, fast turnaround time, and low cost.

In contrast to traditional transgenic techniques, the platform could provide more comprehensive technical services to efficiently generate transgenic mice for researchers worldwide. It covers a wide range of techniques and services, including DNA microinjection, blastocyst injection and tetraploid complementation assay, gene knockin, gene knockout and conditional gene knockout, targeting vector construction, embryo cryopreservation, in vitro fertilization (IVF) and embryo transfer, among others.

Transgenic mice serve as important models for embryonic development and disease pathogenesis research, and their use has dramatically increased for the past two decades. The mice and cell lines derived from them have also accelerated basic research by allowing scientists to relate functions to genes, dissect genetic pathways, and manipulate the cellular or biochemical properties of proteins.

"Based on the handmade cloning and sperm-mediated technologies, we could provide more efficient and economic access to transgenic mice and related research." said, Dr. Yutao Du, Director of BAB, and Vice President of BGI, "We have established a SPF-level facility covering 160 square meters, which could house more than 2,000 mice. The platform also has equipped with the full set of professional experimental equipment and a number of technical experts." she added.

With the high-throughput sequencing platform and profound experience in genomics, BGI Tech in addition provides solutions for gene detection, transgenic mice construction and gene function evaluation. Na Liu, Director of Product Management at BGI Tech, said, "There are significant research and commercial needs for a large scale transgenic mouse platform. We not only can provide the excellent transgenic tech support, but also work with researchers to design professional and personalized solutions. The combination of transgenic technology and high throughput sequencing technology will become an inevitable trend for genetic engineering and make great improvement in biomedical research and applications."


'/>"/>
Contact: Jia Liu
liujia@genomics.cn
BGI Shenzhen
Source:Eurekalert

Related biology news :

1. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
2. Diabetes Research Institute develops oxygen-generating biomaterial
3. Artificial womb unlocks secrets of early embryo development
4. REST is crucial for the timing of brain development
5. Embryonic development protein active in cancer growth
6. Stanford scientists develop gene therapy approach to grow blood vessels in ischemic limbs
7. Mini-CT scanner developed as a teaching tool
8. Genetic research develops tools for studying diseases, improving regenerative treatment
9. Oceanographers develop method for measuring the pace of life in deep sediments
10. Scientists win $2 million to study new pathway in development and maintenance of lymphoma
11. Stomata development in plants unraveled -- a valuable discovery for environmental research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... -- WearablesResearch.com , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... area for financial services, but it also plays a fundamental ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
Breaking Biology Technology: